Our results on the declining levels of specific IgA during the first 6 months after an mRNA vaccine and the individual variability might help explain the mildly symptomatic infections occurring overtime in a rather low proportion of vaccinated subjects during intense viral circulation in the community. This evidence concerns the gene CD79A and infection.